A new study by researchers in Cleveland Clinic's Taussig Cancer Institute and Lerner Research Institute describes a novel class of targeted cancer drugs that may prove effective in treating certain common types of leukemia.
from News Medical Medical Research News Feed https://ift.tt/3oZCmUn
0 Comments